Background: Head-up tilt table testing (HUTT) is time-consuming and associated with increased patient morbidity. Hemodynamic changes that occur during the early phase of HUTT may be predictive of neurocardiogenic syncope. Methods: A retrospective chart review was performed in 119 consecutive African Americans ( 57 ± 19) who underwent HUTT for evaluation of syncope of unknown etiology. Positive responses were defined as the development of symptoms linked with a systolic blood pressure (BP) <90 mm Hg, heart rate <50 b.p.m. or sinus arrest >3 s. Hemodynamic variables during the passive phase of HUTT were analyzed and results were then classified as a function of various predictors. Results: Sixty-two subjects (52%) had positive HUTT, and 57 (48%) had negative HUTT. Early changes in BP variables from baseline significantly predicted HUTT responses (p < 0.05). There was also a significant interaction between age and BP. An algorithm based on age and BP was developed which had positive and negative predictive values of 67.7 and 93%, respectively, with an accuracy of 79.8%. Conclusion: A novel algorithm utilizing the patients' age and changes in both systolic and diastolic BP during the early phase of HUTT enables the prediction of HUTT results without the use of vasoactive stimulation, allowing for rapid diagnosis, decreased patient morbidity and reduction in costs.

Keywords:
Head-up tilt table testing, Hemodynamic changes, Syncope
1.
Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS), et al: Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30:2631-2671.
2.
Almquist A, Goldenberg IF, Milstein S, et al: Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-351.
3.
Kenny RA, Ingram A, Bayliss J, Sutton R: Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1986;i:1352-1355.
4.
Benditt DG, Ferguson DW, Grubb BP, et al: Tilt table testing for assessing syncope. American College of Cardiology. J Am Coll Cardiol 1996;28:263-275.
5.
Bartoletti A, Alboni P, Ammirati F, et al: ‘The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace 2000;2:339-342.
6.
Morillo CA, Klein GJ, Zandri S, Yee R: Diagnostic accuracy of a low-dose isoproterenol head-up tilt protocol. Am Heart J 1995;129:901-906.
7.
Leman RB, Clarke E, Gillette P: Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol 1999;22:675-677.
8.
Asensio E, Oseguera J, Loría A, et al: Clinical findings as predictors of positivity of head-up tilt table test in neurocardiogenic syncope. Arch Med Res 2003;34:287-291.
9.
Kazemi B, Haghjoo M, Arya A, Sadr-Ameli MA: Predictors of response to the head-up tilt test in patients with unexplained syncope or presyncope. Pacing Clin Electrophysiol 2006;29:846-851.
10.
Alvarez JB, Asensio E, Lozano JE, et al: Early heart rate variations during head-up tilt table testing as a predictor of outcome of the test. Pacing Clin Electrophysiol 2000;23:26-31.
11.
Yiu D, Gieroba Z, Hall K, et al: An early drop in systolic blood pressure predicts a positive tilt table test in elderly patients with unexplained falls or syncope. Age Ageing 2006;35:183-185.
12.
Montano N, Ruscone TG, Porta A, et al: Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 1994;90:1826-1831.
13.
Mehlsen J, Kaijer MN, Mehlsen AB: Autonomic and electrocardiographic changes in cardioinhibitory syncope. Europace 2008;10:91-95.
14.
Virag N, Sutton R, Vetter R, et al: Prediction of vasovagal syncope from heart rate and blood pressure trend and variability: experience in 1,155 patients. Heart Rhythm 2007;4:1375-1382.
15.
Guida P, Iacoviello M, Forleo C, et al: Prevalence, timing, and haemodynamic correlates of prodromes in patients with vasovagal syncope induced by head-up tilt test. Europace 2009;11:1221-1226.
16.
Mallat Z, Vicaut E, Sangaré A, et al: Prediction of head-up tilt test result by analysis of early heart rate variations. Circulation 1997;96:581-584.
17.
Movahed MR, Hassapoyannes CA: Prediction of non-occurrence of syncope during a tilt-table test by early heart rate variations. JSC Med Assoc 2001;97:207-210.
18.
Garcia Alberola A, Lacunza Ruiz J, Rojo Alvarez JL, et al: Early heart rate increase does not predict the result of the head-up tilt test potentiated with nitroglycerin (in Spanish). Rev Esp Cardiol 2005;58:499-503.
19.
Soteriades ES, Evans JC, Larson MG, et al: Incidence and prognosis of syncope. N Engl J Med 2002;347:878-885.
20.
Serletis A, Rose S, Sheldon AG, Sheldon RS: Vasovagal syncope in medical students and their first-degree relatives. Eur Heart J 2006;27:1965-1970.
21.
Mark AL: The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;1:90-102.
22.
Brignole M, Menozzi C, Bartoletti A, et al: A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006;27:76-82.
23.
Wallin BG, Sundlof G: Sympathetic outflow to muscles during vasovagal syncope. J Auton Nerv Syst 1982;6:287-291.
24.
Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R: Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125-130.
25.
Forleo C, Guida P, Iacoviello M, et al: Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol 2013;169:e49-e50.
26.
Villamil AM, Perona C, Carnero GS, et al: Evaluation of the behaviour of the time interval from the onset of the QRS complex to the onset of radial and carotid pulse waves with the result of the tilt test (in Spanish). Rev Argent Cardiol 2009;77:1-6.
27.
Elbey MA, Atilgan Z, Cil H, et al: Carotid artery stiffness in patients with neurally mediated syncope. J Ultrasound Med 2012;31:1431-1435.
28.
Gielerak G, Guzik P, Makowski K, et al: Haemodynamic indices of the early phase of the tilt test: does measurement predict outcome? Kardiol Pol 2005;63:244-251; discussion 252-253.
29.
Horowitz B, Miskulin D, Zager P: Epidemiology of hypertension in CKD. Adv Chronic Kidney Dis 2015;22:88-95.
30.
Rodriguez CJ, Soliman EZ, Alonso A, et al: Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol 2015;25:71-76, 76.e1.
31.
Klein KM, Xu SS, Lawrence K, et al: Evidence for genetic factors in vasovagal syncope: a twin-family study. Neurology 2012;79:561-565.
32.
Aydin MA, Maas R, Mortensen K, et al: Predicting recurrence of vasovagal syncope: a simple risk score for the clinical routine. J Cardiovasc Electrophysiol 2009;20:416-421.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.